AVALO THERAPEUTICS INC's ticker is and the CUSIP is 05338F207. A total of 28 filers reported holding AVALO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,250,000 | $444,000 | 0.07% |
| Nantahala Capital Management | 556,202 | $197,563 | 0.02% |
| Virtu Financial LLC | 32,593 | $12 | 0.00% |
| Kistler-Tiffany Companies, LLC | 2 | $1 | 0.00% |
| VANGUARD GROUP INC | 222,073 | $78,880 | 0.00% |
| First Horizon Advisors, Inc. | 276 | $98 | 0.00% |
| UBS Group AG | 1,919 | $680 | 0.00% |
| OSAIC HOLDINGS, INC. | 334 | $118 | 0.00% |
| Parallel Advisors, LLC | 1 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 4,127 | $1,465 | 0.00% |